VBL surges ahead of presentation
March 20, 2015 at 11:40 AM EDT
Shares
of VBL Therapeutics (Nasdaq: VBLT) surged $1.30 to $6.04 ahead of its presentation
today at the BioCentury 22nd Annual Future Leaders in the Biotech
Industry Conference.
